AC Immune (ACIU) Current Assets (2014 - 2025)

AC Immune (ACIU) has 12 years of Current Assets data on file, last reported at $121.0 million in Q4 2025.

• Quarterly Current Assets fell 38.36% year-over-year to $121.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $121.0 million (down 38.36% YoY) and the FY2025 annual result came in at $116.7 million, down 40.58% from the prior year.
• Current Assets eased to $121.0 million in Q4 2025 per ACIU's latest filing, from $142.2 million in the prior quarter.
• Across five years, Current Assets topped out at $243.9 billion in Q1 2021 and bottomed at $97.6 million in Q3 2023.
• The 5-year median for Current Assets is $166.8 million (2022), against an average of $52.1 billion.
• The widest annual swing landed in 2022, when Current Assets tumbled 99.94%; it then surged 106012.48% in 2023.
• Tracing ACIU's Current Assets over 5 years: stood at $219.8 billion in 2021, then plunged by 99.94% to $133.0 million in 2022, then surged by 106012.48% to $141.1 billion in 2023, then tumbled by 99.86% to $196.3 million in 2024, then sank by 38.36% to $121.0 million in 2025.
• Per Business Quant, the three latest ACIU Current Assets figures stand at $121.0 million (Q4 2025), $142.2 million (Q3 2025), and $159.2 million (Q2 2025).

Peer Comparison